Watchlist Price Alert

Evoke Pharma Inc. (EVOK)

NASDAQ: EVOK · Real-Time Price · USD

3.14

-0.01 (-0.48%)

At close: May 13, 2025, 3:39 PM

3.22

2.55%

After-hours: May 13, 2025, 05:15 PM EDT

Evoke Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	13.6M	4.74M	9.84M	9.14M	8.07M	5.66M	5.32M	7.68M	9.01M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	126.92K	241.64K	-129.07K	-12.43K	11.55K	11.55K	11.55K	11.55K	11.55K
Receivables	2.42M	673.07K	624.83K	295.19K	23.31K	n/a	n/a	n/a	n/a
Inventory	445.08K	481.84K	289.38K	185.53K	236.48K	n/a	n/a	n/a	n/a
Other Current Assets	43.9K	47.53K	11.55K	11.55K	30.3K	n/a	n/a	n/a	8K
Total Current Assets	17.24M	6.83M	11.72M	10.56M	9.28M	6.25M	5.65M	7.93M	9.28M
Property-Plant & Equipment	154.18K	n/a	129.07K	12.43K	141.71K	138.54K	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	281.11K	241.64K	129.07K	12.43K	153.26K	150.09K	11.55K	11.55K	11.55K
Total Assets	17.52M	7.07M	11.85M	10.57M	9.43M	6.4M	5.66M	7.94M	9.29M
Account Payables	2.34M	1.71M	868.31K	874.03K	1.27M	1.03M	476.2K	1.05M	478.22K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	-1.03M	n/a	n/a	n/a
Short-Term Debt	5M	5M	129.07K	12.43K	104.17K	138.54K	n/a	n/a	n/a
Other Current Liabilities	2.98M	1.32M	528.08K	506.89K	5M	704.62K	n/a	n/a	n/a
Total Current Liabilities	10.38M	9.65M	1.65M	1.41M	7.54M	2.02M	1.63M	2.07M	1.41M
Long-Term Debt	n/a	5M	5M	5M	5M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	1.61M	1.11M	612.29K	112.99K	n/a	n/a	3.7M	4.1M
Total Long-Term Liabilities	100.96K	6.61M	6.11M	5.61M	5.11M	n/a	n/a	3.7M	4.1M
Total Liabilities	10.48M	9.65M	7.77M	7.02M	12.65M	2.02M	1.63M	5.78M	5.51M
Total Debt	5.16M	5M	5.13M	5.01M	5.25M	138.54K	n/a	n/a	n/a
Common Stock	149.00	334.00	334.00	3.27K	2.66K	2.44K	1.74K	1.54K	1.24K
Retained Earnings	-128,791.6B	-123.44M	-115.65M	-107.42M	-98.89M	-85.73M	-78.6M	-71.04M	-58.81M
Comprehensive Income	n/a	n/a	n/a	n/a	-0.00	n/a	0.00	0.00	n/a
Shareholders Equity	7,038B	-2.58M	4.08M	3.56M	-3.21M	4.38M	4.03M	2.17M	3.79M
Total Investments	13,596.6B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a